Literature DB >> 26419445

Transferrin Receptor 1 in Chronic Hypoxia-Induced Pulmonary Vascular Remodeling.

Yoshiro Naito1, Manami Hosokawa2, Hisashi Sawada2, Makiko Oboshi2, Shinichi Hirotani2, Toshihiro Iwasaku2, Yoshitaka Okuhara2, Daisuke Morisawa2, Akiyo Eguchi2, Koichi Nishimura2, Yuko Soyama2, Kenichi Fujii2, Toshiaki Mano2, Masaharu Ishihara3, Takeshi Tsujino4, Tohru Masuyama2.   

Abstract

BACKGROUND: Iron is associated with the pathophysiology of several cardiovascular diseases, including pulmonary hypertension (PH). In addition, disrupted pulmonary iron homeostasis has been reported in several chronic lung diseases. Transferrin receptor 1 (TfR1) plays a key role in cellular iron transport. However, the role of TfR1 in the pathophysiology of PH has not been well characterized. In this study, we investigate the role of TfR1 in the development of hypoxia-induced pulmonary vascular remodeling.
METHODS: PH was induced by exposing wild-type (WT) mice and TfR1 hetero knockout mice to hypoxia for 4 weeks and evaluated via assessment of pulmonary vascular remodeling, right ventricular (RV) systolic pressure, and RV hypertrophy. In addition, we assessed the functional role of TfR1 in pulmonary artery smooth muscle cells in vitro.
RESULTS: The morphology of pulmonary arteries did not differ between WT mice and TfR1 hetero knockout mice under normoxic conditions. In contrast, TfR1 hetero knockout mice exposed to 4 weeks hypoxia showed attenuated pulmonary vascular remodeling, RV systolic pressure, and RV hypertrophy compared with WT mice. In addition, the depletion of TfR1 by RNA interference attenuated human pulmonary artery smooth muscle cells proliferation induced by platelet-derived growth factor-BB (PDGF-BB) in vitro.
CONCLUSIONS: These results suggest that TfR1 plays an important role in the development of hypoxia-induced pulmonary vascular remodeling. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; pulmonary hypertension; right ventricular hypertrophy; transferrin receptor 1.

Mesh:

Substances:

Year:  2015        PMID: 26419445     DOI: 10.1093/ajh/hpv163

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  13 in total

1.  Iron Metabolism and Vascular Remodeling: Novel Insights Provided by Transferrin-1 Receptor Depletion in Mice With Pulmonary Hypertension.

Authors:  Michael S Wolin; Dhara Patel; Raed Alhawaj; Sachin A Gupte; Dong Sun
Journal:  Am J Hypertens       Date:  2015-11-04       Impact factor: 2.689

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

3.  Protein and lipid fingerprinting of native-like membrane complexes by combining TLC and protein electrophoresis.

Authors:  Elena Lopez-Rodriguez; Nuria Roldan; Begoña Garcia-Alvarez; Jesús Pérez-Gil
Journal:  J Lipid Res       Date:  2018-11-21       Impact factor: 5.922

4.  Endothelin-1 depletion of cartilage oligomeric matrix protein modulates pulmonary artery superoxide and iron metabolism-associated mitochondrial heme biosynthesis.

Authors:  Hang Yu; Norah Alruwaili; Melissa R Kelly; Bin Zhang; Aijing Liu; Yingqi Wang; Dong Sun; Michael S Wolin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-08-09       Impact factor: 6.011

5.  Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.

Authors:  Yoshiro Naito; Manami Hosokawa; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Koichi Nishimura; Yuko Soyama; Shinichi Hirotani; Toshiaki Mano; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-06-16       Impact factor: 2.037

6.  Biomarker Differences between Controlled and Uncontrolled Hypertension among US Adults: National Health and Nutrition Examination Survey 2005-2010.

Authors:  Jung Hye Sung; Jae Eun Lee; Ji-Young Lee
Journal:  Int J Adv Res Sci Eng Technol       Date:  2018-09

7.  Exploring biomarkers associated with deteriorating vascular health using a targeted proteomics chip: The SABPA study.

Authors:  Anna Dieden; Leone Malan; Catharina M C Mels; Leandi Lammertyn; Annemarie Wentzel; Peter M Nilsson; Petri Gudmundsson; Amra Jujic; Martin Magnusson
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 8.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

9.  Deduction of novel genes potentially involved in hypoxic AC16 human cardiomyocytes using next-generation sequencing and bioinformatics approaches.

Authors:  Wen-Hsien Lee; Ming-Ju Tsai; Wei-An Chang; Ling-Yu Wu; Han-Ying Wang; Kuo-Feng Chang; Ho-Ming Su; Po-Lin Kuo
Journal:  Int J Mol Med       Date:  2018-08-31       Impact factor: 4.101

10.  Haploinsufficiency of Transferrin Receptor 1 Impairs Angiogenesis with Reduced Mitochondrial Complex I in Mice with Limb Ischemia.

Authors:  Keisuke Okuno; Yoshiro Naito; Seiki Yasumura; Hisashi Sawada; Masanori Asakura; Tohru Masuyama; Masaharu Ishihara
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.